Tong Ren Tang Technologies Co. Ltd. | Mutual Funds
Mutual Funds that own Tong Ren Tang Technologies Co. Ltd.
First State Global Umbrella Fd. Plc - China Growth Fund
54,880,000
8.73%
-4,175,000
1.83%
09/30/2017
Aberdeen Global - Asian Smaller Companies Fund
12,831,000
2.04%
-3,939,000
1.23%
05/31/2018
Government Pension Fund - Global (The)
10,110,013
1.61%
-3,199,987
0%
12/31/2017
UBS (Lux) Equity Fund - China Opportunity
9,391,000
1.49%
-1,039,000
0.36%
01/31/2018
Vanguard Total International Stock Index Fund
9,233,000
1.47%
0
0%
07/31/2018
Vanguard Emerging Markets Stock Index Fund
8,936,000
1.42%
-140,000
0.02%
07/31/2018
First State Investments ICVC - Greater China Growth Fund
8,758,000
1.39%
-2,743,000
2.11%
01/31/2018
Aberdeen Global - Chinese Equity Fund
7,489,000
1.19%
-500,000
1.82%
04/30/2018
Scottish Oriental Smaller Companies Trust Plc
7,279,000
1.15%
-522,000
2.25%
09/30/2017
Fidelity Invt. Funds - South East Asia Fund
6,876,000
1.09%
0
0.27%
02/28/2018
| Address |
No.20 Nansanhuan Zhonglu
Beijing Beijing 100079
China
|
|
Employees
|
- |
| Website |
http://www.tongrentangkj.com |
| Updated |
07/08/2019 |
| Tong Ren Tang Technologies Co., Ltd. engages in the production and distribution of Chinese medicine. Its products include Liuwei Dihuang pills, Niuhuang Jiedu tablet, Ganmao Qingre granule, Jinkui Shenqi pills, Shengmai liquor, Xihuang pills and Fufang Danshen tablets. The company was founded on March 22, 2000 and is headquartered in Beijing, China. |
